Literature DB >> 26619492

Executive Summary: Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Exposed and HIV-Infected Children: Recommendations From the National Institutes of Health, the Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.

George K Siberry1, Mark J Abzug2, Sharon Nachman3.   

Abstract

The Guidelines for the Prevention and Treatment of Opportunistic Infections (OIs) in HIV-Exposed and HIV-Infected Children in the United States were developed by a panel of specialists in pediatric HIV infection and infectious diseases from the U.S. government and academic institutions, intended for use by clinicians and health care workers providing medical care for HIV-exposed and HIV-infected children in the United States. For each OI, pediatric specialists with subject matter expertise reviewed the literature for new information since the last guidelines were published (2009) and then proposed revised recommendations that were reviewed and approved by the full Panel and endorsing governmental agencies and professional organizations. This executive summary highlights the most important, rated recommendations for each OI from the full Guidelines document. Published by Oxford University Press on behalf of the Pediatric Infectious Diseases Society 2013. This work is written by US Government employees and is in the public domain in the US.

Entities:  

Keywords:  Guidelines; HIV; Opportunistic Infections

Year:  2013        PMID: 26619492      PMCID: PMC6281050          DOI: 10.1093/jpids/pit074

Source DB:  PubMed          Journal:  J Pediatric Infect Dis Soc        ISSN: 2048-7193            Impact factor:   3.164


  52 in total

Review 1.  Antiretroviral therapy: when to start.

Authors:  Christopher J Sellers; David A Wohl
Journal:  Infect Dis Clin North Am       Date:  2014-09       Impact factor: 5.982

Review 2.  Hepatitis B virus vaccination in HIV-infected people: A review.

Authors:  François-Xavier Catherine; Lionel Piroth
Journal:  Hum Vaccin Immunother       Date:  2017-02-16       Impact factor: 3.452

3.  Coinfection of Leishmania guyanensis and Human Immunodeficiency Virus-Acquired Immune Deficiency Syndrome: Report of a Case of Disseminated Cutaneous Leishmaniasis in Ecuador.

Authors:  Manuel Calvopina; Cristina Aguirre; William Cevallos; Alberto Castillo; Ibrahim Abbasi; Alon Warburg
Journal:  Am J Trop Med Hyg       Date:  2017-02-13       Impact factor: 2.345

Review 4.  Toxoplasma gondii and schizophrenia: a review of published RCTs.

Authors:  Sam D Chorlton
Journal:  Parasitol Res       Date:  2017-05-15       Impact factor: 2.289

5.  Seroprotection of HIV-infected subjects after influenza A(H1N1) vaccination is directly associated with baseline frequency of naive T cells.

Authors:  Lorenzo A Ramirez; Alexander Daniel; Ian Frank; Pablo Tebas; Jean D Boyer
Journal:  J Infect Dis       Date:  2014-03-08       Impact factor: 5.226

6.  Tuberculosis screening among HIV-infected patients: tuberculin skin test vs. interferon-gamma release assay.

Authors:  J W Adams; C J Howe; A C Andrews; S L Allen; C Vinnard
Journal:  AIDS Care       Date:  2017-05-09

7.  Acyclovir Prophylaxis Reduces the Incidence of Herpes Zoster Among HIV-Infected Individuals: Results of a Randomized Clinical Trial.

Authors:  Ruanne V Barnabas; Jared M Baeten; Jairam R Lingappa; Katherine K Thomas; James P Hughes; Nelly R Mugo; Sinead Delany-Moretlwe; Glenda Gray; Helen Rees; Andrew Mujugira; Allan Ronald; Wendy Stevens; Saidi Kapiga; Anna Wald; Connie Celum
Journal:  J Infect Dis       Date:  2015-06-08       Impact factor: 5.226

8.  A Randomized Trial of Human Papillomavirus Self-Sampling as an Intervention to Promote Cervical Cancer Screening Among Women With HIV.

Authors:  Jeanne Murphy; Hayley Mark; Jean Anderson; Jason Farley; Jerilyn Allen
Journal:  J Low Genit Tract Dis       Date:  2016-04       Impact factor: 1.925

9.  A Trimethoprim Conjugate of Thiomaltose Has Enhanced Antibacterial Efficacy In Vivo.

Authors:  Xiaojian Wang; Clarissa A Borges; Xinghai Ning; Mohammad Rafi; Jingtuo Zhang; Bora Park; Kiyoko Takemiya; Carlo Lo Sterzo; W Robert Taylor; Lee Riley; Niren Murthy
Journal:  Bioconjug Chem       Date:  2018-04-25       Impact factor: 4.774

Review 10.  Human Immunodeficiency Virus, Other Sexually Transmitted Infections, and Sexual and Reproductive Health in Lesbian, Gay, Bisexual, Transgender Youth.

Authors:  Sarah M Wood; Caroline Salas-Humara; Nadia L Dowshen
Journal:  Pediatr Clin North Am       Date:  2016-12       Impact factor: 3.278

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.